Exact Mass: 356.24368540000006

Exact Mass Matches: 356.24368540000006

Found 500 metabolites which its exact mass value is equals to given mass value 356.24368540000006, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Prostaglandin F1a

7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]heptanoic acid

C20H36O5 (356.2562606)


Prostaglandin F1a is derived mainly from Prostaglandin E1, and is metabolized to 6-Keto Prostaglandin F1a. Prostaglandin F1a is excreted directly into the urine. Prostaglandin F1a contracts the circular muscle of the gut in opposition to the Prostaglandins of the E series. Prostaglandin F1a is a cytoprotector, protecting mucosal tissue from damage produced by ulcerogenic stimuli.Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. Prostaglandin F1a is derived mainly from Prostaglandin E1, and is metabolized to 6-Keto Prostaglandin F1a. Prostaglandin F1a is excreted directly into the urine. Prostaglandin F1a contracts the circular muscle of the gut in opposition to the Prostaglandins of the E series. Prostaglandin F1a is a cytoprotector, protecting mucosal tissue from damage produced by ulcerogenic stimuli.

   

Aacocf3

1,1,1-trifluoro-6Z,9Z,12Z,15Z-heneicosatetraen-2-one

C21H31F3O (356.2326872)


D004791 - Enzyme Inhibitors

   

WIN I(S)

5-(7-(4-(4-Methyl-4,5-dihydrooxazol-2-yl)phenoxy)heptyl)-3-methylisoxazole

C21H28N2O3 (356.20998180000004)


   

Pelanin

(1S,10R,11S,14S,15S)-5-hydroxy-15-methyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2,4,6-trien-14-yl pentanoate

C23H32O3 (356.23513219999995)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen Isolated from potato. Pelanin is found in potato. Same as: D01413

   

16-Dehydropregenolone Acetate

3beta-Acetyloxy-pregna-5,16-dien-20-one

C23H32O3 (356.23513219999995)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

MLS002637687

(17Z)-3,11-Dioxopregna-4,17(20)-dien-21-oic acid methyl ester

C22H28O4 (356.19874880000003)


   

DHA ethyl ester

(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid ethyl ester

C24H36O2 (356.2715156)


C26170 - Protective Agent > C275 - Antioxidant

   

Piperochromanoic acid

2-[(3Z)-4,8-dimethylnona-3,7-dien-1-yl]-8-hydroxy-3-methylidene-3,4-dihydro-2H-1-benzopyran-6-carboxylic acid

C22H28O4 (356.19874880000003)


Piperochromanoic acid is found in herbs and spices. Piperochromanoic acid is a constituent of the leaves of Piper auritum (Veracruz pepper). Constituent of the leaves of Piper auritum (Veracruz pepper). Piperochromanoic acid is found in herbs and spices.

   

Tetracosahexaenoic acid

(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoic acid

C24H36O2 (356.2715156)


The formation of docosahexaenoic acid(DHA) involves the production of tetracosahexaenoic acid C24:6n-3) from dietary linolenic acid (C18:3n-3) via a series of elongation and desaturation reactions, followed by beta-oxidation of C24:6n-3 to C22:6n-3. DHA is deficient in patients lacking peroxisomes.(PMID: 11734571). The formation of docosahexaenoic acid(DHA) involves the production of tetracosahexaenoic acid C24:6n-3) from dietary linolenic acid (C18:3n-3) via a series of elongation and desaturation reactions, followed by beta-oxidation of C24:6n-3 to C22:6n-3.

   

5,7-Megastigmadien-9-ol glucoside

2-(hydroxymethyl)-6-{[(3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-yl]oxy}oxane-3,4,5-triol

C19H32O6 (356.2198772)


5,7-Megastigmadien-9-ol glucoside is found in fruits. 5,7-Megastigmadien-9-ol glucoside is a constituent of Passiflora edulis (passion fruit). Constituent of Passiflora edulis (passion fruit). 5,7-Megastigmadien-9-ol glucoside is found in fruits.

   

gamma-Crocetin

1,16-dimethyl (2Z,4E,6E,8E,10Z,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate

C22H28O4 (356.19874880000003)


gamma-Crocetin is found in herbs and spices. gamma-Crocetin is isolated from saffro Isolated from saffron. gamma-Crocetin is found in saffron and herbs and spices. Crocetine dimethyl ester (Dimethylcrocetin) is found in the stigmas of saffron (Crocus sativus L.), and has antioxidant activity[1].

   

13,14-Dihydro PGE1

7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoctyl]-5-oxocyclopentyl]heptanoic acid

C20H36O5 (356.2562606)


13,14-dihydro PGE1 is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 13,14-dihydro PGE1 is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207)

   

13,14-Dihydro PGF2a

(5E)-7-[3,5-dihydroxy-2-(3-hydroxyoctyl)cyclopentyl]hept-5-enoic acid

C20H36O5 (356.2562606)


13,14-dihydro PGF2a is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 13,14-dihydro PGF2a is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207)

   

Tetracosahexaenoic acid (24:6n-3)

tetracosa-6,9,12,15,18,21-hexaenoic acid

C24H36O2 (356.2715156)


6,9,12,15,18,21-Tetracosahexaenoic acid (24:6n-3) is one of the n-3 PUFA and is a very long chain fatty acid. Distribution of 24:6n-3 in marine organisms was investigated by several researchers. Takagi et al. reported relatively high contents of 24:6n-3 in sea lilies and brittle stars (4–10\\% of total fatty acids). High 24:6n-3 content was also found in marine coelenterates. In some edible fishes, 24:6n-3 was detected at significant levels (0–10\\% of total fatty acids).The existence of 24:6n-3 in mammalian tissues was reported with other very long chain fatty acids in the spermatozoa,the retina, and the brain. Voss et al. reported that 24:6n-3 is formed as an intermediate in the metabolic pathway from 20:5n-3 to 22:6n-3 in rat liver. Even though 24:6n-3 is a PUFA existing in fish and mammalian species, physiological functions of 24:6n-3 have not been studied. As functions to be studied, anti-inflammatory and antiallergic. effects of 24:6n-3 are noteworthy because these events are known to be closely related to the unsaturated fatty acid metabolism such as in the arachidonic acid cascade, and 20:5n-3 and 22:6n-3 were reported to suppress inflammatory actions by influencing arachidonic acid metabolism.s24:6n-3 could inhibit the antigen-stimulated production of LT-related compounds as well as other n-3 polyunsaturated fatty acids (PUFA) such as eicosapentaenoic. acid (20:5n-3) and docosahexaenoic acid (22:6n-3), which are major n-3 PUFA in fish oils; 24:6n-3 was also shown to reduce the histamine content in MC/9 cells at 25 uM (27\\% reduction from the control), and the effect was diminished with increase of the fatty acid concentration (up to 100 uM). These two n-3 PUFA, 20:5n-3 and 22:6n-3, also reduced the histamine content (16 and 20\\% reduction at 25 μM, respectively), whereas arachidonic acid (20:4n-6) increased it (18\\% increase at 25 μM).

   

1-Formylneogrifolin

4,5-dihydroxy-2-methyl-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzaldehyde

C23H32O3 (356.23513219999995)


1-Formylneogrifolin is found in mushrooms. 1-Formylneogrifolin is a constituent of Albatrellus ovinus. Constituent of Albatrellus ovinus. 1-Formylneogrifolin is found in mushrooms.

   

Dopexamine

4-[2-({6-[(2-phenylethyl)amino]hexyl}amino)ethyl]benzene-1,2-diol

C22H32N2O2 (356.24636519999996)


C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists Dopexamine is a 1 and 2-adrenergic receptor agonist. It also acts at dopamine receptors. C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Tetracosahexaenoic acid, n-3

(7Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-7,9,12,15,18,21-hexaenoic acid

C24H36O2 (356.2715156)


This compound belongs to the family of Straight Chain Fatty Acids. These are fatty acids with a straight aliphatic chain.

   

N-Lauroyl Arginine

5-[(diaminomethylidene)amino]-2-dodecanamidopentanoic acid

C18H36N4O3 (356.2787266)


N-lauroyl arginine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Arginine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Arginine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Arginine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Myristoyl Glutamine

4-carbamoyl-2-tetradecanamidobutanoic acid

C19H36N2O4 (356.2674936)


N-myristoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Glutamine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

7-[3-Hydroxy-2-(3-hydroxyoctyl)-5-oxocyclopentyl]heptanoic acid

7-[3-Hydroxy-2-(3-hydroxyoctyl)-5-oxocyclopentyl]heptanoic acid

C20H36O5 (356.2562606)


   

13,14-Dihydroprostaglandin F2alpha

7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3S)-3-hydroxyoctyl]cyclopentyl]hept-5-enoate

C20H36O5 (356.2562606)


   

8-Epi pgf1alpha

7-[3,5-dihydroxy-2-(3-hydroxyoct-1-en-1-yl)cyclopentyl]heptanoic acid

C20H36O5 (356.2562606)


   

Docosa-4,7,10,13,16,19-hexaenoic acid ethyl ester

Docosa-4,7,10,13,16,19-hexaenoic acid ethyl ester

C24H36O2 (356.2715156)


   

Aacocf3

1,1,1-trifluorohenicosa-6,9,12,15-tetraen-2-one

C21H31F3O (356.2326872)


   

AB-Chminaca

N-(1-(Aminocarbonyl)-2-methylpropyl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide

C20H28N4O2 (356.2212148)


   

2,4,6,8,10,12-Docosahexaenoic acid, ethyl ester

(all-Z)-Isomer, no locants for unsaturation OF 4,7,10,13,16,19-docosahexaenoic acid ethyl ester

C24H36O2 (356.2715156)


   

Estradiol 3-Valerate

(17-Hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl) pentanoate

C23H32O3 (356.23513219999995)


   

Estradiol valerate

5-Hydroxy-15-methyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2,4,6-trien-14-yl pentanoic acid

C23H32O3 (356.23513219999995)


   

Rolofylline

1,3-dipropyl-8-{tricyclo[3.3.1.0³,⁷]nonan-3-yl}-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C20H28N4O2 (356.2212148)


   

Tetracosahexaenic acid

tetracosa-2,4,6,8,10,12-hexaenoic acid

C24H36O2 (356.2715156)


   

n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide

n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide

C22H32N2O2 (356.24636519999996)


   

vamorolone

14-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1(17),3,6-trien-5-one

C22H28O4 (356.19874880000003)


   

6-[Ethyl-(3-isobutoxy-4-isopropylphenyl)amino]nicotinic acid

6-{ethyl[3-(2-methylpropoxy)-4-(propan-2-yl)phenyl]amino}pyridine-3-carboxylic acid

C21H28N2O3 (356.20998180000004)


   

Prostaglandin F-1-alpha

7-{3,5-dihydroxy-2-[(1E)-3-hydroxyoct-1-en-1-yl]cyclopentyl}heptanoic acid

C20H36O5 (356.2562606)


Prostaglandin f-1-alpha is a member of the class of compounds known as prostaglandins and related compounds. Prostaglandins and related compounds are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. Prostaglandin f-1-alpha is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Prostaglandin f-1-alpha can be found in soft-necked garlic, which makes prostaglandin f-1-alpha a potential biomarker for the consumption of this food product.

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

1-Methyl-2-acetyl-6-hexanoyl-7-methoxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole

1-Methyl-2-acetyl-6-hexanoyl-7-methoxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole

C21H28N2O3 (356.20998180000004)


   

2alpha,3alpha,4beta,15,16-Pentahydroxy-ent-cleroda-13Z-ene

2alpha,3alpha,4beta,15,16-Pentahydroxy-ent-cleroda-13Z-ene

C20H36O5 (356.2562606)


   

Neogrifolin dimethyl ether

E,E-5-Methyl-4-(3,7,11-trimethyl-2,6,10-dodecatrienyl)-1,3-dimethoxybenzene

C24H36O2 (356.2715156)


   
   
   

3-(Hydroperoxymethyl)-6-(1-hydroxy-1-methylundecyl)-4-methoxy-2H-pyran-2-one

3-(Hydroperoxymethyl)-6-(1-hydroxy-1-methylundecyl)-4-methoxy-2H-pyran-2-one

C19H32O6 (356.2198772)


   

Nitenin

(2S) -8- (3-Hydroxy-3-methylbutyl) -5,7-dimethoxy-2alpha-phenylchroman

C22H28O4 (356.19874880000003)


   

Diethyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate

Diethyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate

C19H33O4P (356.21163480000007)


   
   

ethyl docosahexaenate

ethyl docosahexaenate

C24H36O2 (356.2715156)


   

Niaprazine

Niaprazine

C20H25FN4O (356.20122919999994)


N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic Niaprazine is a histamine H1-receptor antagonist. Niaprazine has antihistamine and antiserotonin activities and can be used for sleep disorder research[1][2].

   

N-(1-amino-3-methyl-1-oxobutan-2-yl)-2-(cyclohexylmethyl)-2h-indazole-3-carboxamide

N-(1-amino-3-methyl-1-oxobutan-2-yl)-2-(cyclohexylmethyl)-2h-indazole-3-carboxamide

C20H28N4O2 (356.2212148)


   

2,4-dihydroxy-6-methyl-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzaldehyde

2,4-dihydroxy-6-methyl-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzaldehyde

C23H32O3 (356.23513219999995)


   

4-muurolen-7,15-diol, 15-(2-phenylacetate) ester

4-muurolen-7,15-diol, 15-(2-phenylacetate) ester

C23H32O3 (356.23513219999995)


   

16beta-hydroxy-5alpha-pregna-1,20-dien-3-one 16-acetate

16beta-hydroxy-5alpha-pregna-1,20-dien-3-one 16-acetate

C23H32O3 (356.23513219999995)


   
   

5-heptadeca-8(Z),11(Z),14(Z)-trienylresorsinol monomethyl ether

5-heptadeca-8(Z),11(Z),14(Z)-trienylresorsinol monomethyl ether

C24H36O2 (356.2715156)


   
   
   
   
   
   
   
   

1-acetyl-aspidospermidine-16,17-diol|N-Acetyl-16,17-dihydroxy-aspidospermin|O-Demethylaspidocarpine

1-acetyl-aspidospermidine-16,17-diol|N-Acetyl-16,17-dihydroxy-aspidospermin|O-Demethylaspidocarpine

C21H28N2O3 (356.20998180000004)


   
   
   
   

14-dehydrouzarigenin|3beta-hydroxy-5alpha-carda-14(15),20(22)-dienolide|3beta-Hydroxy-5alpha-carda-14,20(22)-dienolid|3beta-hydroxy-5alpha-carda-14,20(22)-dienolide|beta-anhydroepidigitoxigenin

14-dehydrouzarigenin|3beta-hydroxy-5alpha-carda-14(15),20(22)-dienolide|3beta-Hydroxy-5alpha-carda-14,20(22)-dienolid|3beta-hydroxy-5alpha-carda-14,20(22)-dienolide|beta-anhydroepidigitoxigenin

C23H32O3 (356.23513219999995)


   
   

ent-dihydrotucumanoic acid

ent-dihydrotucumanoic acid

C20H36O5 (356.2562606)


   

agallochin B|ent-15-chloro-13,14-dihydroxylabd-8(9)-en-3-one

agallochin B|ent-15-chloro-13,14-dihydroxylabd-8(9)-en-3-one

C20H33ClO3 (356.2118098000001)


   
   

1-Formylneogrifolin

4,5-dihydroxy-2-methyl-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzaldehyde

C23H32O3 (356.23513219999995)


   

Tridachiapyrone E|tridachiapyrone-E

Tridachiapyrone E|tridachiapyrone-E

C22H28O4 (356.19874880000003)


   
   
   
   

Leu-Gln-Pro

Leu-Gln-Pro

C16H28N4O5 (356.2059598)


A tripeptide consisting of L-leucyl, L-glutaminyl and L-proline residues joined in sequence.

   

3-oxo-tirucall-7-ene-3,20-dione|dysolenticin G

3-oxo-tirucall-7-ene-3,20-dione|dysolenticin G

C24H36O2 (356.2715156)


   

1-Acetyl-aspidospermidin-3alpha,17-diol|1-acetyl-aspidospermidine-3alpha,17-diol|Spegazzinin, 3-Hydroxy-17-demethyl-(-)-aspidospermin|Spegazzinine

1-Acetyl-aspidospermidin-3alpha,17-diol|1-acetyl-aspidospermidine-3alpha,17-diol|Spegazzinin, 3-Hydroxy-17-demethyl-(-)-aspidospermin|Spegazzinine

C21H28N2O3 (356.20998180000004)


   
   
   
   
   

2,11beta-Dimethoxy-19-nor-17alpha-pregna-1,3,5(10)trien-20-yn-3,17beta-diol

2,11beta-Dimethoxy-19-nor-17alpha-pregna-1,3,5(10)trien-20-yn-3,17beta-diol

C22H28O4 (356.19874880000003)


   
   
   

3-oxo-ent-13-epi-8(13)-epoxy-15-chloro-14-hydroxylabdane|agallochin A

3-oxo-ent-13-epi-8(13)-epoxy-15-chloro-14-hydroxylabdane|agallochin A

C20H33ClO3 (356.2118098000001)


   

3-(hydroperoxymethyl)-6-(2-hydroxydodecan-2-yl)-4-methoxy-2H-pyran-2-one|peroxymonascuspyrone

3-(hydroperoxymethyl)-6-(2-hydroxydodecan-2-yl)-4-methoxy-2H-pyran-2-one|peroxymonascuspyrone

C19H32O6 (356.2198772)


   

3beta-acetoxy-5alpha-pregn-7,20-dien-6-one

3beta-acetoxy-5alpha-pregn-7,20-dien-6-one

C23H32O3 (356.23513219999995)


   

rel-(1R,2R)-2-(1-farnesyl-2-hydroxy-5-oxocyclohex-3-en-1-yl)-acetic acid lactone

rel-(1R,2R)-2-(1-farnesyl-2-hydroxy-5-oxocyclohex-3-en-1-yl)-acetic acid lactone

C23H32O3 (356.23513219999995)


   

19(S)-hydroxy-Nb-methylraumacline|19(S)-hydroxy-Nbeta-methylraumacline

19(S)-hydroxy-Nb-methylraumacline|19(S)-hydroxy-Nbeta-methylraumacline

C21H28N2O3 (356.20998180000004)


   
   

4xi,5xi,11-trihydroxygermacran-6-yl (Z)-2-methylbut-2-enoate

4xi,5xi,11-trihydroxygermacran-6-yl (Z)-2-methylbut-2-enoate

C20H36O5 (356.2562606)


   

12,13-dimethoxy-ibogamin-20-ol|Epi-19-iboxygalin

12,13-dimethoxy-ibogamin-20-ol|Epi-19-iboxygalin

C21H28N2O3 (356.20998180000004)


   

(6E)-1-(2,4-dihydroxyphenyl)-3,7,11-trimethyl-3-vinyl-6,10-dodecadien-1-one|1-(2,4-dihydroxyphenyl)-3,7,11-trimethyl-3-vinyl-6(E),10-dodecadiene-1-one

(6E)-1-(2,4-dihydroxyphenyl)-3,7,11-trimethyl-3-vinyl-6,10-dodecadien-1-one|1-(2,4-dihydroxyphenyl)-3,7,11-trimethyl-3-vinyl-6(E),10-dodecadiene-1-one

C23H32O3 (356.23513219999995)


   

TETRACOSA-4,8,12,15,18,21-HEXAENOIC ACID

TETRACOSA-4,8,12,15,18,21-HEXAENOIC ACID

C24H36O2 (356.2715156)


   
   
   
   
   

16,17-Dihydrosecodin-17-ol|2-{3-[2-(5-ethyl-3,6-dihydro-2H-pyridin-1-yl)-ethyl]-indol-2-yl}-3-hydroxy-propionic acid methyl ester

16,17-Dihydrosecodin-17-ol|2-{3-[2-(5-ethyl-3,6-dihydro-2H-pyridin-1-yl)-ethyl]-indol-2-yl}-3-hydroxy-propionic acid methyl ester

C21H28N2O3 (356.20998180000004)


   
   
   

19-furan-2-ylnonadeca-5,7-diynoic acid

19-furan-2-ylnonadeca-5,7-diynoic acid

C23H32O3 (356.23513219999995)


   
   
   

Lehualide I

Lehualide I

C19H32O4S (356.2021192)


A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by methoxy groups at positions 3 and 4, a methyl group at position 5 and a 10-(methylsulfanyl)decyl group at position 6. Isolated from the marine sponge of the genus Plakortis, it exhibits cytotoxicity against human promyeloid leukemic HL-60 cells.

   

1a,2,6,7,7a,7b-hexahydro-3-hydroxy-1-octyl-7-oxo-1H-cyclobut[bc]acenaphthylene-5-carboxylic acid|beilschmiedic acid G

1a,2,6,7,7a,7b-hexahydro-3-hydroxy-1-octyl-7-oxo-1H-cyclobut[bc]acenaphthylene-5-carboxylic acid|beilschmiedic acid G

C22H28O4 (356.19874880000003)


   
   
   

bendigole B

24-nor-12alpha-hydroxy-cholest-1,4-dien-3,22-dione

C23H32O3 (356.23513219999995)


   

3-oxopregna-1,4-dien-20-yl acetate

3-oxopregna-1,4-dien-20-yl acetate

C23H32O3 (356.23513219999995)


   

4beta-hydroxy-6alpha-benzoyl-7-daucen-9-one|feruhermonin A

4beta-hydroxy-6alpha-benzoyl-7-daucen-9-one|feruhermonin A

C22H28O4 (356.19874880000003)


   
   

3-(hydroxymethyl)-1,13,14,15-tetrahydroxy-7,11,15-trimethyl-2,6,10-hexadecatriene

3-(hydroxymethyl)-1,13,14,15-tetrahydroxy-7,11,15-trimethyl-2,6,10-hexadecatriene

C20H36O5 (356.2562606)


   

19-acetoxypregna-4,20-dien-3-one|sclerosteroid K

19-acetoxypregna-4,20-dien-3-one|sclerosteroid K

C23H32O3 (356.23513219999995)


   

10,17-O-cyclo-4,5-diepi-dactylospongiaquinone

10,17-O-cyclo-4,5-diepi-dactylospongiaquinone

C22H28O4 (356.19874880000003)


   

(E)-3-(3,7-dimethyl-1-oxo-2,6-octadienyl)-4-hydroxy-5-(3-methyl-2-butenyl)benzoic acid

(E)-3-(3,7-dimethyl-1-oxo-2,6-octadienyl)-4-hydroxy-5-(3-methyl-2-butenyl)benzoic acid

C22H28O4 (356.19874880000003)


   

(6R,9R)-3-oxo-alpha-ionol-9-O-beta-D-glucopyranoside|4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-ol

(6R,9R)-3-oxo-alpha-ionol-9-O-beta-D-glucopyranoside|4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-ol

C19H32O6 (356.2198772)


   

(4E,7E)-1-(2,4-dihydroxyphenyl)-3,4,8,12-tetramethyltrideca-4,7,11-trien-1-one|ferulaeone C

(4E,7E)-1-(2,4-dihydroxyphenyl)-3,4,8,12-tetramethyltrideca-4,7,11-trien-1-one|ferulaeone C

C23H32O3 (356.23513219999995)


   
   
   
   

(-)-octalactin A|4(R),5(S),8(S)-4-hydroxy-8-{2-[3-((S)-2-hydroxy-3-methyl-butyl)-2(S),3(R)-2-methyl-oxiranyl]-1(S)-methyl-2-oxo-ethyl}-5-methyl-oxocan-2-one|Octalactin A

(-)-octalactin A|4(R),5(S),8(S)-4-hydroxy-8-{2-[3-((S)-2-hydroxy-3-methyl-butyl)-2(S),3(R)-2-methyl-oxiranyl]-1(S)-methyl-2-oxo-ethyl}-5-methyl-oxocan-2-one|Octalactin A

C19H32O6 (356.2198772)


   

11alpha-acetoxy-pregna-4,20-dien-3-one

11alpha-acetoxy-pregna-4,20-dien-3-one

C23H32O3 (356.23513219999995)


   
   

15alpha-methoxy-O-methyldihydrobotrydial

15alpha-methoxy-O-methyldihydrobotrydial

C19H32O6 (356.2198772)


   

(4E,8E,12Z)-13-hydroxymethylene-1-(2-hydroxyphenyl)-5,9-dimethyl-4,8,12-tetradecatrien-1-one|(4E,8E,12Z)-form-13-(Hydroxymethyl)-1-(2-hydroxyphenyl)-5,9-dimethyl-4,8,12-tetradecatrien-1-one

(4E,8E,12Z)-13-hydroxymethylene-1-(2-hydroxyphenyl)-5,9-dimethyl-4,8,12-tetradecatrien-1-one|(4E,8E,12Z)-form-13-(Hydroxymethyl)-1-(2-hydroxyphenyl)-5,9-dimethyl-4,8,12-tetradecatrien-1-one

C23H32O3 (356.23513219999995)


   

(-)-O-ethyl-14-epimelohenine B|(3alpha,14alpha,16alpha)-14,15-dihydro-2,7-secoeburnamenine-2,7-dione|(6aS,7S,1bS)-16-ethoxy-7-ethyl-7,8,9,19,12,13-hexahydro-14H-5,7-ethanopyrido[2,1-c][1,4]benzodiazonine-6,14(6aH)-dione

(-)-O-ethyl-14-epimelohenine B|(3alpha,14alpha,16alpha)-14,15-dihydro-2,7-secoeburnamenine-2,7-dione|(6aS,7S,1bS)-16-ethoxy-7-ethyl-7,8,9,19,12,13-hexahydro-14H-5,7-ethanopyrido[2,1-c][1,4]benzodiazonine-6,14(6aH)-dione

C21H28N2O3 (356.20998180000004)


   
   

3,12-dioxo-23,24-dinor-chola-4,6-dien-22-oic acid|3,12-Dioxo-23,24-dinor-chola-4,6-dien-22-saeure|3,12-dioxo-23,24-dinorchola-4,6-dienoic acid

3,12-dioxo-23,24-dinor-chola-4,6-dien-22-oic acid|3,12-Dioxo-23,24-dinor-chola-4,6-dien-22-saeure|3,12-dioxo-23,24-dinorchola-4,6-dienoic acid

C22H28O4 (356.19874880000003)


   
   

methyl (3S*,6S*)-3,6-epidioxy-6-methoxyoctadec-4-enoate

methyl (3S*,6S*)-3,6-epidioxy-6-methoxyoctadec-4-enoate

C20H36O5 (356.2562606)


   
   

rel-(1R,5R)-2-(1-farnesyl-5-hydroxy-2-oxocyclohex-3-en-1-yl)-acetic acid delta-lactone

rel-(1R,5R)-2-(1-farnesyl-5-hydroxy-2-oxocyclohex-3-en-1-yl)-acetic acid delta-lactone

C23H32O3 (356.23513219999995)


   
   
   
   

3-hydroxy-3,4-seco-coronaridine|3-Hydroxy-3,4-secocoronaridine

3-hydroxy-3,4-seco-coronaridine|3-Hydroxy-3,4-secocoronaridine

C21H28N2O3 (356.20998180000004)


   
   

16-beta-acetyloxy-pregn-4,17(20)-trans-dien-3-one|16beta-acetyloxy-pregn-4,17(20)-(trans)-dien-3-one

16-beta-acetyloxy-pregn-4,17(20)-trans-dien-3-one|16beta-acetyloxy-pregn-4,17(20)-(trans)-dien-3-one

C23H32O3 (356.23513219999995)


   

4,5,16,18-Trihydroxy-4,5-seco-5-rosanone|ent-4xi,15xi,16,18-tetrahydroxypictan-5-one

4,5,16,18-Trihydroxy-4,5-seco-5-rosanone|ent-4xi,15xi,16,18-tetrahydroxypictan-5-one

C20H36O5 (356.2562606)


   

5alpha-4-hydroxybenzoylferujaesenol

5alpha-4-hydroxybenzoylferujaesenol

C22H28O4 (356.19874880000003)


   
   

2-acetoxy-1,15-beyeradiene-3,12-dione

2-acetoxy-1,15-beyeradiene-3,12-dione

C22H28O4 (356.19874880000003)


   
   
   
   
   
   

3-farnesyl4-methoxybenzoic acid

3-farnesyl4-methoxybenzoic acid

C23H32O3 (356.23513219999995)


   
   
   
   
   
   
   
   
   
   
   

Lagochiline

Lagochiline

C20H36O5 (356.2562606)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.144 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.146 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.143

   

(2-{4,5-Dimethoxy-2-[2-(4-methoxy-phenyl)-vinyl]-phenyl}-ethyl)-trimethyl-ammonium

"NCGC00160197-01!(2-{4,5-Dimethoxy-2-[2-(4-methoxy-phenyl)-vinyl]-phenyl}-ethyl)-trimethyl-ammonium"

[C22H30NO3]+ (356.22255700000005)


   

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid

NCGC00380990-01!(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid

C19H32O6 (356.2198772)


   

2,4-dihydroxy-6-methyl-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzaldehyde

NCGC00347603-02!2,4-dihydroxy-6-methyl-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzaldehyde

C23H32O3 (356.23513219999995)


   

C22H28O4_Benzene, 1,2,3-trimethoxy-5-[2-[4-[(3-methyl-2-buten-1-yl)oxy]phenyl]ethyl]

NCGC00381261-01_C22H28O4_Benzene, 1,2,3-trimethoxy-5-[2-[4-[(3-methyl-2-buten-1-yl)oxy]phenyl]ethyl]-

C22H28O4 (356.19874880000003)


   

Eicosanoids_PGF1?_C20H36O5

Eicosanoids_PGF1?_C20H36O5

C20H36O5 (356.2562606)


   

Lagochilin

Lagochilin

C20H36O5 (356.2562606)


Origin: Plant; SubCategory_DNP: Diterpenoids, Lagochilin diterpenoids

   
   

9,13-Epoxy-3,15,16,18-labdanetetrol

9,13-Epoxy-3,15,16,18-labdanetetrol

C20H36O5 (356.2562606)


Origin: Plant; SubCategory_DNP: Diterpenoids, Labdane diterpenoids

   

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid [IIN-based on: CCMSLIB00000847299]

NCGC00380990-01!(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid [IIN-based on: CCMSLIB00000847299]

C19H32O6 (356.2198772)


   

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid [IIN-based on: CCMSLIB00000847297]

NCGC00380990-01!(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid [IIN-based on: CCMSLIB00000847297]

C19H32O6 (356.2198772)


   

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid [IIN-based: Match]

NCGC00380990-01!(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid [IIN-based: Match]

C19H32O6 (356.2198772)


   
   

Ala Ala Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C16H28N4O5 (356.2059598)


   

Ala Ala Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Ala Gly Ile Pro

(2S)-1-[(2S,3S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Ala Gly Leu Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Ala Gly Pro Ile

(2S,3S)-2-{[(2S)-1-{2-[(2S)-2-aminopropanamido]acetyl}pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C16H28N4O5 (356.2059598)


   

Ala Gly Pro Leu

(2S)-2-{[(2S)-1-{2-[(2S)-2-aminopropanamido]acetyl}pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C16H28N4O5 (356.2059598)


   

Ala Ile Gly Pro

(2S)-1-{2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]acetyl}pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Ala Ile Pro Gly

2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C16H28N4O5 (356.2059598)


   

Ala Leu Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]acetyl}pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Ala Leu Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C16H28N4O5 (356.2059598)


   

Ala Pro Ala Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-methylbutanoic acid

C16H28N4O5 (356.2059598)


   

Ala Pro Gly Ile

(2S,3S)-2-(2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-methylpentanoic acid

C16H28N4O5 (356.2059598)


   

Ala Pro Gly Leu

(2S)-2-(2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}acetamido)-4-methylpentanoic acid

C16H28N4O5 (356.2059598)


   

Ala Pro Ile Gly

2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]acetic acid

C16H28N4O5 (356.2059598)


   

Ala Pro Leu Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]acetic acid

C16H28N4O5 (356.2059598)


   

Ala Pro Val Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]propanoic acid

C16H28N4O5 (356.2059598)


   

Ala Val Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]propanoyl]pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Ala Val Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C16H28N4O5 (356.2059598)


   

Gly Ala Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Gly Ala Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Gly Ala Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)propanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C16H28N4O5 (356.2059598)


   

Gly Ala Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)propanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C16H28N4O5 (356.2059598)


   

Gly Ile Ala Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Gly Ile Pro Ala

(2S)-2-{[(2S)-1-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C16H28N4O5 (356.2059598)


   

Gly Leu Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Gly Leu Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-methylpentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C16H28N4O5 (356.2059598)


   

Gly Pro Ala Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}propanamido]-3-methylpentanoic acid

C16H28N4O5 (356.2059598)


   

Gly Pro Ala Leu

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}propanamido]-4-methylpentanoic acid

C16H28N4O5 (356.2059598)


   

Gly Pro Ile Ala

(2S)-2-[(2S,3S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylpentanamido]propanoic acid

C16H28N4O5 (356.2059598)


   

Gly Pro Leu Ala

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-methylpentanamido]propanoic acid

C16H28N4O5 (356.2059598)


   

Ile Ala Gly Pro

(2S)-1-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]acetyl}pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Ile Ala Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanoyl]pyrrolidin-2-yl]formamido}acetic acid

C16H28N4O5 (356.2059598)


   

Ile Gly Ala Pro

(2S)-1-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}propanoyl]pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Ile Gly Pro Ala

(2S)-2-{[(2S)-1-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetyl}pyrrolidin-2-yl]formamido}propanoic acid

C16H28N4O5 (356.2059598)


   

Ile Pro Ala Gly

2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}propanamido]acetic acid

C16H28N4O5 (356.2059598)


   

Ile Pro Gly Ala

(2S)-2-(2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}acetamido)propanoic acid

C16H28N4O5 (356.2059598)


   
   
   

Leu Ala Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]acetyl}pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Leu Ala Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanoyl]pyrrolidin-2-yl]formamido}acetic acid

C16H28N4O5 (356.2059598)


   
   

Leu Gly Ala Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}propanoyl]pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Leu Gly Pro Ala

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-4-methylpentanamido]acetyl}pyrrolidin-2-yl]formamido}propanoic acid

C16H28N4O5 (356.2059598)


   
   

Leu Pro Ala Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}propanamido]acetic acid

C16H28N4O5 (356.2059598)


   

Leu Pro Gly Ala

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}acetamido)propanoic acid

C16H28N4O5 (356.2059598)


   

Pro Ala Ala Val

(2S)-3-methyl-2-[(2S)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanoic acid

C16H28N4O5 (356.2059598)


   

Pro Ala Gly Ile

(2S,3S)-3-methyl-2-{2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}pentanoic acid

C16H28N4O5 (356.2059598)


   

Pro Ala Gly Leu

(2S)-4-methyl-2-{2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}pentanoic acid

C16H28N4O5 (356.2059598)


   

Pro Ala Ile Gly

2-[(2S,3S)-3-methyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]acetic acid

C16H28N4O5 (356.2059598)


   

Pro Ala Leu Gly

2-[(2S)-4-methyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]acetic acid

C16H28N4O5 (356.2059598)


   

Pro Ala Val Ala

(2S)-2-[(2S)-3-methyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]propanoic acid

C16H28N4O5 (356.2059598)


   

Pro Gly Ala Ile

(2S,3S)-3-methyl-2-[(2S)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]pentanoic acid

C16H28N4O5 (356.2059598)


   

Pro Gly Ala Leu

(2S)-4-methyl-2-[(2S)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]pentanoic acid

C16H28N4O5 (356.2059598)


   

Pro Gly Ile Ala

(2S)-2-[(2S,3S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]propanoic acid

C16H28N4O5 (356.2059598)


   

Pro Gly Leu Ala

(2S)-2-[(2S)-4-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]propanoic acid

C16H28N4O5 (356.2059598)


   

Pro Ile Ala Gly

2-[(2S)-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]acetic acid

C16H28N4O5 (356.2059598)


   

Pro Ile Gly Ala

(2S)-2-{2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}propanoic acid

C16H28N4O5 (356.2059598)


   

Pro Leu Ala Gly

2-[(2S)-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]acetic acid

C16H28N4O5 (356.2059598)


   

Pro Leu Gly Ala

(2S)-2-{2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}propanoic acid

C16H28N4O5 (356.2059598)


   

Pro Val Ala Ala

(2S)-2-[(2S)-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]propanoic acid

C16H28N4O5 (356.2059598)


   
   
   
   
   
   

Dopexamine

4-[2-[6-(2-phenylethylamino)hexylamino]ethyl]benzene-1,2-diol

C22H32N2O2 (356.24636519999996)


C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Val Ala Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C16H28N4O5 (356.2059598)


   

Val Ala Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C16H28N4O5 (356.2059598)


   

Val Pro Ala Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}propanamido]propanoic acid

C16H28N4O5 (356.2059598)


   

4,8,12,15,19,21-tetracosahexaenoic acid

4,8,12,15,19,21-tetracosahexaenoic acid

C24H36O2 (356.2715156)


   

PGF1&beta

9R,11R,15S-trihydroxy-13E-prostaenoic acid

C20H36O5 (356.2562606)


   

13,14-dihydro PGF2&alpha

9α,11α,15S-trihydroxy-prost-5Z-en-1-oic acid

C20H36O5 (356.2562606)


   

13,14-dihydro-PGE1

9-oxo-11R,15S-dihydroxy-prostanoic acid

C20H36O5 (356.2562606)


   

dhk-PGF1&alpha

13,14-dihydro-15-keto-Prostaglandin F1α

C20H36O5 (356.2562606)


   

13,14-dihydro-15-keto-PGD2-d4

11,15-dioxo-9S-hydroxy-5Z-prostenoic acid-d4

C20H28D4O5 (356.250070912)


   

PGD2-d4

(Z)-3,3,4,4-tetradeuterio-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid

C20H28D4O5 (356.250070912)


   

PGE2-d4

(Z)-3,3,4,4-tetradeuterio-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid

C20H28D4O5 (356.250070912)


   

5β-Chola-8(14),11-dien-24-oic Acid

5β-Chola-8(14),11-dien-24-oic Acid

C24H36O2 (356.2715156)


   

5β-Chola-7,9(11)-dien-24-oic Acid

5β-Chola-7,9(11)-dien-24-oic Acid

C24H36O2 (356.2715156)


   

5β-Chola-3,11-dien-24-oic Acid

5β-Chola-3,11-dien-24-oic Acid

C24H36O2 (356.2715156)


   
   

13,14-dihydro-15(R)-Prostaglandin E1

9-oxo-11α,15R-dihydroxy-prostan-1-oic acid

C20H36O5 (356.2562606)


   

8-iso Prostaglandin F1&alpha

9α,11α,15S-trihydroxy-(8)-prost-13E-en-1-oic acid

C20H36O5 (356.2562606)


   

8-iso Prostaglandin F1&beta

9β,11α,15S-trihydroxy-(8β)-prost-13E-en-1-oic acid

C20H36O5 (356.2562606)


   

11β-Prostaglandin F1&beta

9β,11β,15S-trihydroxy-prost-13E-en-1-oic acid

C20H36O5 (356.2562606)


   

25,26,27-trinor-23-ene-1alpha(OH)D3

(1S)-1-hydroxy-23,24-didehydro-25,26,27-trinorcholecalciferol

C24H36O2 (356.2715156)


   

chola-4,6-dien-24-oic acid

chola-4,6-dien-24-oic acid

C24H36O2 (356.2715156)


   

Docosahexaenoic acid ethyl ester

cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester

C24H36O2 (356.2715156)


   

tetracosahexaenoic acid

2E,4E,6E,8E,10E,12E-tetracosahexaenoic acid

C24H36O2 (356.2715156)


   

(R,E)-S-2-acetamido-13-(methylamino)-13-oxotridec-3-enyl ethanethioate

(R,E)-S-2-acetamido-13-(methylamino)-13-oxotridec-3-enyl ethanethioate

C18H32N2O3S (356.21335220000003)


   

C24:6n-3,5,9,12,16,20

4,8,12,15,19,21-tetracosahexaenoic acid

C24H36O2 (356.2715156)


   

Nisinic acid

6Z,9Z,12Z,15Z,18Z,21Z-tetracosahexaenoic acid

C24H36O2 (356.2715156)


   

methyl 9-hydroperoxy-10,12-epidioxy-13,15-octadecadienoate

methyl 9-hydroperoxy-10,12-epidioxy-13,15-octadecadienoate

C19H32O6 (356.2198772)


   

methyl 13,15-epidioxy-16-hydroperoxy-9,11-octadecadienoate

methyl 13,15-epidioxy-16-hydroperoxy-9,11-octadecadienoate

C19H32O6 (356.2198772)


   

methyl 10,12-epidioxy-13-hydroperoxy-8E,15Z-octadecadienoate

methyl 10,12-epidioxy-13-hydroperoxy-8E,15Z-octadecadienoate

C19H32O6 (356.2198772)


   

methyl 13,15-epidioxy-12-hydroperoxy-9Z,16E-octadecadienoate

methyl 13,15-epidioxy-12-hydroperoxy-9Z,16E-octadecadienoate

C19H32O6 (356.2198772)


   

methyl 9,12-dihydroperoxy-10E,13E,15Z-octadecatrienoate

methyl 9,12-dihydroperoxy-10E,13E,15Z-octadecatrienoate

C19H32O6 (356.2198772)


   

methyl 9,16-dihydroperoxy-10E,12,14E-octadecatrienoate

methyl 9,16-dihydroperoxy-10E,12,14E-octadecatrienoate

C19H32O6 (356.2198772)


   

methyl 13,16-dihydroperoxy-9Z,11E,14E-octadecatrienoate

methyl 13,16-dihydroperoxy-9Z,11E,14E-octadecatrienoate

C19H32O6 (356.2198772)


   

methyl 10,12-dihydroperoxy-8E,13E,15Z-octadecatrienoate

methyl 10,12-dihydroperoxy-8E,13E,15Z-octadecatrienoate

C19H32O6 (356.2198772)


   

methyl 13,15-dihydroperoxy-9Z,11E,16E-octadecatrienoate

methyl 13,15-dihydroperoxy-9Z,11E,16E-octadecatrienoate

C19H32O6 (356.2198772)


   

methyl 10,16-dihydroperoxy-8E,12Z,14E-octadecatrienoate

methyl 10,16-dihydroperoxy-8E,12Z,14E-octadecatrienoate

C19H32O6 (356.2198772)


   

methyl 9,15-dihydroperoxy-10E,12Z,16E-octadecatrienoate

methyl 9,15-dihydroperoxy-10E,12Z,16E-octadecatrienoate

C19H32O6 (356.2198772)


   

methyl 11-(3,5-epidioxy-2-ethyl-cyclopentyl)-9-hydroperoxy-10-undecenoate

methyl 11-(3,5-epidioxy-2-ethyl-cyclopentyl)-9-hydroperoxy-10-undecenoate

C19H32O6 (356.2198772)


   

methyl 9-hydroperoxy-10,13-epdioxy-11,15-octadecadienoate

methyl 9-hydroperoxy-10,13-epdioxy-11,15-octadecadienoate

C19H32O6 (356.2198772)


   

methyl 12,15-epdioxy-16-hydroperoxy-9,13-octadecadienoate

methyl 12,15-epdioxy-16-hydroperoxy-9,13-octadecadienoate

C19H32O6 (356.2198772)


   

g-Crocetin

1,16-dimethyl (2Z,4E,6E,8E,10Z,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate

C22H28O4 (356.19874880000003)


Crocetine dimethyl ester (Dimethylcrocetin) is found in the stigmas of saffron (Crocus sativus L.), and has antioxidant activity[1].

   

Piperochromanoic acid

2-[(3Z)-4,8-dimethylnona-3,7-dien-1-yl]-8-hydroxy-3-methylidene-3,4-dihydro-2H-1-benzopyran-6-carboxylic acid

C22H28O4 (356.19874880000003)


   

5,7-Megastigmadien-9-ol glucoside

2-(hydroxymethyl)-6-{[(3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-yl]oxy}oxane-3,4,5-triol

C19H32O6 (356.2198772)


   

13,14-dihydro-15-keto Prostaglandin D2-d4

13,14-dihydro-15-keto Prostaglandin D2-d4

C20H28D4O5 (356.250070912)


   

8-iso Prostaglandin E2-d4

8-iso Prostaglandin E2-d4

C20H28D4O5 (356.250070912)


   

FA 24:6

(6E,9E,12E,15E,18E,21E)-tetracosa-6,9,12,15,18,21-hexaenoic acid

C24H36O2 (356.2715156)


   

24:6n3

6Z,9Z,12Z,15Z,18Z,21Z-tetracosahexaenoic acid

C24H36O2 (356.2715156)


   

FA 19:3;O4

methyl 11-(3,5-epidioxy-2-ethyl-cyclopentyl)-9-hydroperoxy-10-undecenoate

C19H32O6 (356.2198772)


   

PGF1beta

9R,11R,15S-trihydroxy-13E-prostaenoic acid

C20H36O5 (356.2562606)


   

FA 20:2;O3

13,14-dihydro-15-keto-Prostaglandin F1alpha

C20H36O5 (356.2562606)


   

FA 22:8;O2

(5E,7E)-8-[(3aR,4R,5R,7aS)-4-[(1Z,3E)-5-hydroxy-5-oxopenta-1,3-dienyl]-2,3,3a,4,5,7a-hexahydro-1H-inden-5-yl]octa-5,7-dienoic acid

C22H28O4 (356.19874880000003)


   

FAL 26:12

(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-hexacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-dodecaenal

C26H28O (356.2140038)


   

14:0-Gln

N-tetradecanoyl glutamine

C19H36N2O4 (356.2674936)


   

ST 24:3;O2

5beta-Chola-8(14),11-dien-24-oic Acid

C24H36O2 (356.2715156)


   

Sinubrasone D

methyl 24-dinor-3-oxo-chola-1,4-dien-22-oate

C23H32O3 (356.23513219999995)


   

U-69593

n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide

C22H32N2O2 (356.24636519999996)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics U-69593 is a potent and selective κ1-opioid receptor agonist[1]. U-69593 attenuates addictive agent-induced behavioral sensitization in the rat[2]. U-69593 reduces anxiety and enhances spontaneous alternation memory in mice[3]. U-69593 reduces calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum[4].

   

(9β,11β,16α)-9,11-Epoxy-21-hydroxy-16-methyl-pregna-1,4-diene-3,20-dione

(9β,11β,16α)-9,11-Epoxy-21-hydroxy-16-methyl-pregna-1,4-diene-3,20-dione

C22H28O4 (356.19874880000003)


   

4,4-(1,10-Decanediyl)dioxydianiline

4,4-(1,10-Decanediyl)dioxydianiline

C22H32N2O2 (356.24636519999996)


   
   

2-[4-(cyanomethyl)-2,5-dihexoxyphenyl]acetonitrile

2-[4-(cyanomethyl)-2,5-dihexoxyphenyl]acetonitrile

C22H32N2O2 (356.24636519999996)


   

1-octadecanesulfonic acid sodium salt

1-octadecanesulfonic acid sodium salt

C18H37NaO3S (356.2360972)


   

Pyrimidine, 2-[4-[1-(1-cyclohexyl-1H-tetrazol-5-yl)propyl]-1-piperazinyl]- (9CI)

Pyrimidine, 2-[4-[1-(1-cyclohexyl-1H-tetrazol-5-yl)propyl]-1-piperazinyl]- (9CI)

C18H28N8 (356.2436808)


   

7-(2,5-dihydroxy-3,4,6-trimethylphenyl)-7-phenylheptanoic acid

7-(2,5-dihydroxy-3,4,6-trimethylphenyl)-7-phenylheptanoic acid

C22H28O4 (356.19874880000003)


   

ethyl prop-2-enoate,8-methyl-2-methylidenenonanoic acid,prop-2-enoic acid

ethyl prop-2-enoate,8-methyl-2-methylidenenonanoic acid,prop-2-enoic acid

C19H32O6 (356.2198772)


   

butyl 2-methylprop-2-enoate,butyl prop-2-enoate,2-methylprop-2-enoic acid

butyl 2-methylprop-2-enoate,butyl prop-2-enoate,2-methylprop-2-enoic acid

C19H32O6 (356.2198772)


   

N,N-dimethyl-3-(6-phenylpyrido[2,3-b][1,4]benzodiazepin-11-yl)propan-1-amine

N,N-dimethyl-3-(6-phenylpyrido[2,3-b][1,4]benzodiazepin-11-yl)propan-1-amine

C23H24N4 (356.2000864)


   

quinestradol

quinestradol

C23H32O3 (356.23513219999995)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

ethenyl acetate,6-methylheptyl prop-2-enoate,2-methylprop-2-enoic acid

ethenyl acetate,6-methylheptyl prop-2-enoate,2-methylprop-2-enoic acid

C19H32O6 (356.2198772)


   
   

Lauroyl D-Arginate

N2-(1-Oxododecyl)-DL-arginine

C18H36N4O3 (356.2787266)


   

(N-tert-Butoxycarbonyl-N-[(1R)-hydroxy-1-phenyl)ethyl])-4-aminophenylethylamine

(N-tert-Butoxycarbonyl-N-[(1R)-hydroxy-1-phenyl)ethyl])-4-aminophenylethylamine

C21H28N2O3 (356.20998180000004)


   

cis-1,2-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)stilbene

cis-1,2-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)stilbene

C20H30B2O4 (356.23300800000004)


   

1-adamantylmethyl-5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

1-adamantylmethyl-5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

C21H33BN2O2 (356.2634948)


   

Pregna-9(11),16-dien-20-one,3-(acetyloxy)-, (3b,5a)-

Pregna-9(11),16-dien-20-one,3-(acetyloxy)-, (3b,5a)-

C23H32O3 (356.23513219999995)


   
   

Diethyl 3,5-di-tert-butyl-4-hydroxybenzyl phosphate

Diethyl 3,5-di-tert-butyl-4-hydroxybenzyl phosphate

C19H33O4P (356.21163480000007)


   

ETHYLTRIBUTYLPHOSPHONIUM ETHYL SULFATE

ETHYLTRIBUTYLPHOSPHONIUM ETHYL SULFATE

C16H37O4PS (356.21500520000006)


   

Isoxazole, 5-(7-(4-((4R)-4,5-dihydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl-

Isoxazole, 5-(7-(4-((4R)-4,5-dihydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl-

C21H28N2O3 (356.20998180000004)


   

Rolofylline

Rolofylline

C20H28N4O2 (356.2212148)


D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Rolofylline (KW-3902) is a potent, selective adenosine A1 receptor antagonist that is under development for the treatment of patients with acute congestive heart failure and renal impairment. Rolofylline is metabolized primarily to the pharmacologically active M1-trans and M1-cis metabolites by cytochrome P450 (CYP450)[1]. Rolofylline is alleviating the presynaptic dysfunction and restores neuronal activity as well as dendritic spine levels in vitro, is an interesting candidate to combat the hypometabolism and neuronal dysfunction associated with Tau-induced neurodegenerative diseases[2].

   

Cyclizine Lactate

Cyclizine Lactate

C21H28N2O3 (356.20998180000004)


C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent

   

4,7,10,13,16,19-docosahexaenoic acid ethyl ester

ethyl (2E,4E,6E,8E,10E,12E)-docosa-2,4,6,8,10,12-hexaenoate

C24H36O2 (356.2715156)


   

N-Methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]benzeneacetamide

N-Methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]benzeneacetamide

C22H32N2O2 (356.24636519999996)


   

5-Amino-5-oxo-2-tetradecanamidopentanoic acid

5-Amino-5-oxo-2-tetradecanamidopentanoic acid

C19H36N2O4 (356.2674936)


   

Ilicicolin B

Ilicicolin B

C23H32O3 (356.23513219999995)


An ilicicolin that is 2,4-dihydroxy-6-methyl-benzaldehyde which is substituted at position 3 by a (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl group.

   

19-(2-Furyl)nonadeca-5,7-diynoic acid

19-(2-Furyl)nonadeca-5,7-diynoic acid

C23H32O3 (356.23513219999995)


An acetylenic fatty acid that is nonadeca-5,7-diynoic acid substituted by a furan-2-yl group at position 19. Isolated from Polyalthia evecta, it exhibits anti-HSV-1 and antiplasmodial activity.

   

N-[3-(1-azepanyl)propyl]-2-cyclohexyl-2-phenylacetamide

N-[3-(1-azepanyl)propyl]-2-cyclohexyl-2-phenylacetamide

C23H36N2O (356.2827486)


   

L-leucyl-L-glutaminyl-L-proline

L-leucyl-L-glutaminyl-L-proline

C16H28N4O5 (356.2059598)


   

6-((tert-Butyldiphenylsilyl)oxy)hexan-1-ol

6-((tert-Butyldiphenylsilyl)oxy)hexan-1-ol

C22H32O2Si (356.21714519999995)


   

(11alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid

(11alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid

C20H36O5 (356.2562606)


   

(2R,2R,5S,5R,6S,8aS)-5-(2-hydroxyethyl)-5,5-bis(hydroxymethyl)-2,5,8a-trimethyldecahydro-2H,3H-spiro[furan-2,1-naphthalen]-6-ol

(2R,2R,5S,5R,6S,8aS)-5-(2-hydroxyethyl)-5,5-bis(hydroxymethyl)-2,5,8a-trimethyldecahydro-2H,3H-spiro[furan-2,1-naphthalen]-6-ol

C20H36O5 (356.2562606)


   

1H-Purine-2,6-dione, 8-(hexahydro-2,5-methanopentalen-3a(1H)-yl)-3,7-dihydro-1,3-dipropyl-

1H-Purine-2,6-dione, 8-(hexahydro-2,5-methanopentalen-3a(1H)-yl)-3,7-dihydro-1,3-dipropyl-

C20H28N4O2 (356.2212148)


C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

   

Estradiol valerate

Estradiol valerate

C23H32O3 (356.23513219999995)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen

   

6,9,12,15,18,21-Tetracosahexaenoic acid

6,9,12,15,18,21-Tetracosahexaenoic acid

C24H36O2 (356.2715156)


   

13,14-dihydroprostaglandin F2α

13,14-Dihydroprostaglandin F2alpha

C20H36O5 (356.2562606)


A prostaglandins Falpha that is prost-5-en-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15.

   

22-Oxocholest-4-en-3-one

22-Oxocholest-4-en-3-one

C24H36O2 (356.2715156)


   

2-[4-[[4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-1-ium-2-yl]amino]butyl]guanidine

2-[4-[[4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-1-ium-2-yl]amino]butyl]guanidine

C14H26N7O4+ (356.2046176)


   

[(1S,2R,3R,4S,5S,6S)-4-azaniumyl-3-[(2R,3R,4R,5S,6R)-3-azaniumyl-6-(azaniumylmethyl)-4,5-dihydroxyoxan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]-methylazanium

[(1S,2R,3R,4S,5S,6S)-4-azaniumyl-3-[(2R,3R,4R,5S,6R)-3-azaniumyl-6-(azaniumylmethyl)-4,5-dihydroxyoxan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]-methylazanium

C13H32N4O7+4 (356.2270882)


   

(6E,9E,12E,15E)-1,1,1-trifluorohenicosa-6,9,12,15-tetraen-2-one

(6E,9E,12E,15E)-1,1,1-trifluorohenicosa-6,9,12,15-tetraen-2-one

C21H31F3O (356.2326872)


D004791 - Enzyme Inhibitors

   

[3-carboxy-2-[(E)-tridec-8-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tridec-8-enoyl]oxypropyl]-trimethylazanium

C20H38NO4+ (356.28006880000004)


   

[3-Carboxy-2-(8-carboxy-3,4-dimethylideneoctanoyl)oxypropyl]-trimethylazanium

[3-Carboxy-2-(8-carboxy-3,4-dimethylideneoctanoyl)oxypropyl]-trimethylazanium

C18H30NO6+ (356.207302)


   

[3-carboxy-2-[(6E,9E)-3-hydroxydodeca-6,9-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(6E,9E)-3-hydroxydodeca-6,9-dienoyl]oxypropyl]-trimethylazanium

C19H34NO5+ (356.24368540000006)


   

[3-carboxy-2-[(5E,7E)-3-hydroxydodeca-5,7-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(5E,7E)-3-hydroxydodeca-5,7-dienoyl]oxypropyl]-trimethylazanium

C19H34NO5+ (356.24368540000006)


   

[3-carboxy-2-[(7E,9E)-5-hydroxydodeca-7,9-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(7E,9E)-5-hydroxydodeca-7,9-dienoyl]oxypropyl]-trimethylazanium

C19H34NO5+ (356.24368540000006)


   

[3-carboxy-2-[(7E,10E)-3-hydroxydodeca-7,10-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(7E,10E)-3-hydroxydodeca-7,10-dienoyl]oxypropyl]-trimethylazanium

C19H34NO5+ (356.24368540000006)


   

[3-carboxy-2-[(5E,8E)-2-hydroxydodeca-5,8-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(5E,8E)-2-hydroxydodeca-5,8-dienoyl]oxypropyl]-trimethylazanium

C19H34NO5+ (356.24368540000006)


   

[3-carboxy-2-[(8E,10E)-6-hydroxydodeca-8,10-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(8E,10E)-6-hydroxydodeca-8,10-dienoyl]oxypropyl]-trimethylazanium

C19H34NO5+ (356.24368540000006)


   

[3-carboxy-2-[(6E,10E)-3-hydroxydodeca-6,10-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(6E,10E)-3-hydroxydodeca-6,10-dienoyl]oxypropyl]-trimethylazanium

C19H34NO5+ (356.24368540000006)


   

[3-carboxy-2-[(6E,8E)-4-hydroxydodeca-6,8-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(6E,8E)-4-hydroxydodeca-6,8-dienoyl]oxypropyl]-trimethylazanium

C19H34NO5+ (356.24368540000006)


   

[3-carboxy-2-[(4E,6E)-2-hydroxydodeca-4,6-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(4E,6E)-2-hydroxydodeca-4,6-dienoyl]oxypropyl]-trimethylazanium

C19H34NO5+ (356.24368540000006)


   

[3-carboxy-2-[(E)-tridec-3-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tridec-3-enoyl]oxypropyl]-trimethylazanium

C20H38NO4+ (356.28006880000004)


   

[3-carboxy-2-[(E)-tridec-5-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tridec-5-enoyl]oxypropyl]-trimethylazanium

C20H38NO4+ (356.28006880000004)


   

[3-carboxy-2-[(E)-tridec-11-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tridec-11-enoyl]oxypropyl]-trimethylazanium

C20H38NO4+ (356.28006880000004)


   

[3-carboxy-2-[(E)-tridec-2-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tridec-2-enoyl]oxypropyl]-trimethylazanium

C20H38NO4+ (356.28006880000004)


   

[3-carboxy-2-[(E)-tridec-4-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tridec-4-enoyl]oxypropyl]-trimethylazanium

C20H38NO4+ (356.28006880000004)


   

[3-carboxy-2-[(E)-tridec-6-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tridec-6-enoyl]oxypropyl]-trimethylazanium

C20H38NO4+ (356.28006880000004)


   

[3-carboxy-2-[(E)-tridec-9-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tridec-9-enoyl]oxypropyl]-trimethylazanium

C20H38NO4+ (356.28006880000004)


   

[3-carboxy-2-[(E)-tridec-7-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tridec-7-enoyl]oxypropyl]-trimethylazanium

C20H38NO4+ (356.28006880000004)


   

[3-carboxy-2-[(E)-tridec-10-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tridec-10-enoyl]oxypropyl]-trimethylazanium

C20H38NO4+ (356.28006880000004)


   

Dysolenticin G

Dysolenticin G

C24H36O2 (356.2715156)


A tetracyclic triterpenoid found in Dysoxylum lenticellatum.

   

Ethyl docosahexaenoate

Ethyl docosahexaenoate

C24H36O2 (356.2715156)


C26170 - Protective Agent > C275 - Antioxidant

   

Ethanol, 2-[2-[4-[(3-phenoxyphenyl)methyl]-1-piperazinyl]ethoxy]-

Ethanol, 2-[2-[4-[(3-phenoxyphenyl)methyl]-1-piperazinyl]ethoxy]-

C21H28N2O3 (356.20998180000004)


   

7-[(1R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]heptanoic acid

7-[(1R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]heptanoic acid

C20H36O5 (356.2562606)


   

rel-(R)-1-((8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)ethyl acetate

rel-(R)-1-((8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)ethyl acetate

C23H32O3 (356.23513219999995)


A natural product found in Carijoa multiflora.

   

8-iso Prostaglandin F1alpha

8-iso Prostaglandin F1alpha

C20H36O5 (356.2562606)


   

4-[[4-(2,3-Dimethylphenyl)-1-piperazinyl]methyl]-2,6-dimethoxyphenol

4-[[4-(2,3-Dimethylphenyl)-1-piperazinyl]methyl]-2,6-dimethoxyphenol

C21H28N2O3 (356.20998180000004)


   

pentanoic acid [(13S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] ester

pentanoic acid [(13S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] ester

C23H32O3 (356.23513219999995)


   
   
   
   

5-(1-adamantyl)-N-[2-(dimethylamino)ethyl]-2-methoxybenzamide

5-(1-adamantyl)-N-[2-(dimethylamino)ethyl]-2-methoxybenzamide

C22H32N2O2 (356.24636519999996)


   

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid

C19H32O6 (356.2198772)


   

(5S,8S)-5-(2-methylpropyl)-8-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

(5S,8S)-5-(2-methylpropyl)-8-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

C20H28N4O2 (356.2212148)


   

1-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

1-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

C17H32N4O4 (356.24234320000005)


   

1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

C17H32N4O4 (356.24234320000005)


   

1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

C17H32N4O4 (356.24234320000005)


   

N-[3-(dimethylamino)propyl]-2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C17H32N4O4 (356.24234320000005)


   

N-[3-(dimethylamino)propyl]-2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C17H32N4O4 (356.24234320000005)


   

(4S,7S)-7-(2-methylpropyl)-4-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4S,7S)-7-(2-methylpropyl)-4-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C20H28N4O2 (356.2212148)


   

N-[[(2R,3R,4R)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-N-propan-2-ylcyclobutanecarboxamide

N-[[(2R,3R,4R)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-N-propan-2-ylcyclobutanecarboxamide

C22H32N2O2 (356.24636519999996)


   

1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

C17H32N4O4 (356.24234320000005)


   

1-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

1-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

C17H32N4O4 (356.24234320000005)


   

1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

C17H32N4O4 (356.24234320000005)


   

1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

C17H32N4O4 (356.24234320000005)


   

1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-3-propylurea

C17H32N4O4 (356.24234320000005)


   

N-[3-(dimethylamino)propyl]-2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C17H32N4O4 (356.24234320000005)


   

N-[3-(dimethylamino)propyl]-2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C17H32N4O4 (356.24234320000005)


   

N-[3-(dimethylamino)propyl]-2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C17H32N4O4 (356.24234320000005)


   

N-[3-(dimethylamino)propyl]-2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C17H32N4O4 (356.24234320000005)


   

N-[3-(dimethylamino)propyl]-2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C17H32N4O4 (356.24234320000005)


   

N-[3-(dimethylamino)propyl]-2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[oxo-(propan-2-ylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C17H32N4O4 (356.24234320000005)


   

(4S,7R)-7-(2-methylpropyl)-4-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4S,7R)-7-(2-methylpropyl)-4-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C20H28N4O2 (356.2212148)


   

(4R,7R)-7-(2-methylpropyl)-4-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4R,7R)-7-(2-methylpropyl)-4-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C20H28N4O2 (356.2212148)


   

(4R,7S)-7-(2-methylpropyl)-4-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4R,7S)-7-(2-methylpropyl)-4-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C20H28N4O2 (356.2212148)


   

(5S,8R)-5-(2-methylpropyl)-8-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

(5S,8R)-5-(2-methylpropyl)-8-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

C20H28N4O2 (356.2212148)


   

N-[[(2S,3S,4S)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-N-propan-2-ylcyclobutanecarboxamide

N-[[(2S,3S,4S)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-N-propan-2-ylcyclobutanecarboxamide

C22H32N2O2 (356.24636519999996)


   

cyclopentyl-[(2R,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-1-yl]methanone

cyclopentyl-[(2R,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-1-yl]methanone

C22H32N2O2 (356.24636519999996)


   

(1S,5R)-7-[4-(2-methylphenyl)phenyl]-3-(5-pyrimidinylmethyl)-3,6-diazabicyclo[3.1.1]heptane

(1S,5R)-7-[4-(2-methylphenyl)phenyl]-3-(5-pyrimidinylmethyl)-3,6-diazabicyclo[3.1.1]heptane

C23H24N4 (356.2000864)


   
   
   
   
   
   
   
   

[(8R,9S,13S,14R,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate

[(8R,9S,13S,14R,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate

C23H32O3 (356.23513219999995)


   

2-[4,5-dimethoxy-2-[(E)-2-(4-methoxyphenyl)ethenyl]phenyl]ethyl-trimethylazanium

2-[4,5-dimethoxy-2-[(E)-2-(4-methoxyphenyl)ethenyl]phenyl]ethyl-trimethylazanium

C22H30NO3+ (356.22255700000005)


   

5-(2-Hydroxyethyl)-5,5-bis(hydroxymethyl)-2,5,8A-trimethyl-octahydro-2H-spiro[naphthalene-1,2-oxolan]-6-OL

5-(2-Hydroxyethyl)-5,5-bis(hydroxymethyl)-2,5,8A-trimethyl-octahydro-2H-spiro[naphthalene-1,2-oxolan]-6-OL

C20H36O5 (356.2562606)


   

(R)-6-(tert-Butyldimethylsilyloxy)-8-pivaloyloxy-2-methyl-2-octene

(R)-6-(tert-Butyldimethylsilyloxy)-8-pivaloyloxy-2-methyl-2-octene

C20H40O3Si (356.274657)


   

(1-hydroxy-3-propanoyloxypropan-2-yl) (Z)-tetradec-9-enoate

(1-hydroxy-3-propanoyloxypropan-2-yl) (Z)-tetradec-9-enoate

C20H36O5 (356.2562606)


   

(1-acetyloxy-3-hydroxypropan-2-yl) (Z)-pentadec-9-enoate

(1-acetyloxy-3-hydroxypropan-2-yl) (Z)-pentadec-9-enoate

C20H36O5 (356.2562606)


   

(1-butanoyloxy-3-hydroxypropan-2-yl) (Z)-tridec-9-enoate

(1-butanoyloxy-3-hydroxypropan-2-yl) (Z)-tridec-9-enoate

C20H36O5 (356.2562606)


   

2-[(3-Heptoxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(3-Heptoxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C15H35NO6P+ (356.22018800000006)


   

PGF1alpha

(13E,15S)-9alpha,11alpha-9,11,15-Trihydroxyprost-13-en-1-Oic acid

C20H36O5 (356.2562606)


   

ST 23:4;O3

17-pentanoyl-estra-1,3,5(10)-triene-3,17beta-diol

C23H32O3 (356.23513219999995)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen Same as: D01413

   

13,14-Dihydrodinoprost

13,14-dihydroprostaglandin F2α

C20H36O5 (356.2562606)


   

11,15-Dihydroxy-9-oxoprostan-1-oic acid

7-[3-Hydroxy-2-(3-hydroxyoctyl)-5-oxocyclopentyl]heptanoic acid

C20H36O5 (356.2562606)


   

Tetracosahexaenoic acid, n-3

Tetracosahexaenoic acid, n-3

C24H36O2 (356.2715156)


   

Prostaglandin F1beta

Prostaglandin F1beta

C20H36O5 (356.2562606)


   

13,14-dihydro-15-keto-PGF1α

9S,11R-dihydroxy-15-oxo-prostanoic acid

C20H36O5 (356.2562606)


   

N-myristoyl glutamine

N-myristoyl glutamine

C19H36N2O4 (356.2674936)


   

5beta-Chola-3,11-dien-24-oic Acid

5beta-Chola-3,11-dien-24-oic Acid

C24H36O2 (356.2715156)


   

prostaglandin F1a

prostaglandin F1a

C20H36O5 (356.2562606)


   

(1S)-1-hydroxy-23,24-didehydro-25,26,27-trinorcalciol

(1S)-1-hydroxy-23,24-didehydro-25,26,27-trinorcalciol

C24H36O2 (356.2715156)


   

5beta-Chola-7,9(11)-dien-24-oic Acid

5beta-Chola-7,9(11)-dien-24-oic Acid

C24H36O2 (356.2715156)


   

5beta-Chola-8(14),11-dien-24-oic Acid

5beta-Chola-8(14),11-dien-24-oic Acid

C24H36O2 (356.2715156)


   

(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosahexaenoic acid

(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosahexaenoic acid

C24H36O2 (356.2715156)


A very long-chain polyunsaturated fatty acid that is tetracosanoic acid having six double bonds located at positions 6, 9, 12, 15, 18 and 21 (the (6Z,9Z,12Z,15Z,18Z,21Z-isomer).

   

DG(17:1)

DG(6:0_11:1)

C20H36O5 (356.2562606)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   

(1z)-2-{1-[(1z)-hex-1-en-1-yl[(1-hydroxyethylidene)amino]amino]-3-hydroxy-1-oxopropan-2-yl}-1-hexyldiazen-1-ium-1-olate

(1z)-2-{1-[(1z)-hex-1-en-1-yl[(1-hydroxyethylidene)amino]amino]-3-hydroxy-1-oxopropan-2-yl}-1-hexyldiazen-1-ium-1-olate

C17H32N4O4 (356.24234320000005)


   

1,5-diisocyano-2,5-dimethyl-8-[2-methyl-5-(prop-1-en-2-yl)oxolan-2-yl]-octahydronaphthalen-2-ol

1,5-diisocyano-2,5-dimethyl-8-[2-methyl-5-(prop-1-en-2-yl)oxolan-2-yl]-octahydronaphthalen-2-ol

C22H32N2O2 (356.24636519999996)


   

(2e,4s)-4-[(2s,3s,4r,5s,6s,8r,9s,10r)-9-ethyl-4,10-dihydroxy-3,5,8-trimethyl-1,7-dioxaspiro[5.5]undecan-2-yl]pent-2-enoic acid

(2e,4s)-4-[(2s,3s,4r,5s,6s,8r,9s,10r)-9-ethyl-4,10-dihydroxy-3,5,8-trimethyl-1,7-dioxaspiro[5.5]undecan-2-yl]pent-2-enoic acid

C19H32O6 (356.2198772)


   

(1r,2r,3r,4ar,5s,6r,8ar)-5-[(3z)-5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1,5,6,8a-tetramethyl-hexahydro-2h-naphthalene-1,2,3-triol

(1r,2r,3r,4ar,5s,6r,8ar)-5-[(3z)-5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1,5,6,8a-tetramethyl-hexahydro-2h-naphthalene-1,2,3-triol

C20H36O5 (356.2562606)


   

2,4-dihydroxy-6-methyl-3-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzaldehyde

2,4-dihydroxy-6-methyl-3-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzaldehyde

C23H32O3 (356.23513219999995)


   

methyl 3-{[(1r,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-4-hydroxybenzoate

methyl 3-{[(1r,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-4-hydroxybenzoate

C23H32O3 (356.23513219999995)


   

(1s,2e,4r,7z,11s,12s)-11-chloro-8-(hydroxymethyl)-1-isopropyl-4,12-dimethyl-15-oxabicyclo[10.2.1]pentadeca-2,7-dien-4-ol

(1s,2e,4r,7z,11s,12s)-11-chloro-8-(hydroxymethyl)-1-isopropyl-4,12-dimethyl-15-oxabicyclo[10.2.1]pentadeca-2,7-dien-4-ol

C20H33ClO3 (356.2118098000001)


   

(1-{hex-1-en-1-yl[(1-hydroxyethylidene)amino]amino}-3-hydroxy-1-oxopropan-2-yl)(hexyl-oxo-λ⁵-azanylidene)amine

(1-{hex-1-en-1-yl[(1-hydroxyethylidene)amino]amino}-3-hydroxy-1-oxopropan-2-yl)(hexyl-oxo-λ⁵-azanylidene)amine

C17H32N4O4 (356.24234320000005)


   

3-[(4-hydroxyphenyl)methyl]-5-methyl-6-(8-methylnonyl)-1h-pyrazin-2-one

3-[(4-hydroxyphenyl)methyl]-5-methyl-6-(8-methylnonyl)-1h-pyrazin-2-one

C22H32N2O2 (356.24636519999996)


   

methyl 3-{[(1r,2s,4as,8as)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl}-4-hydroxybenzoate

methyl 3-{[(1r,2s,4as,8as)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl}-4-hydroxybenzoate

C23H32O3 (356.23513219999995)


   

(4r,5s,8s)-4-hydroxy-8-[(2s)-1-[(2s,3r)-3-[(2s)-2-hydroxy-3-methylbutyl]-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-5-methyloxocan-2-one

(4r,5s,8s)-4-hydroxy-8-[(2s)-1-[(2s,3r)-3-[(2s)-2-hydroxy-3-methylbutyl]-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-5-methyloxocan-2-one

C19H32O6 (356.2198772)


   

(3r)-5-[(1s,2r,4ar,5r,6r,7r,8ar)-5,6,7-trihydroxy-1,2,4a,5-tetramethyl-hexahydro-2h-naphthalen-1-yl]-3-methylpentanoic acid

(3r)-5-[(1s,2r,4ar,5r,6r,7r,8ar)-5,6,7-trihydroxy-1,2,4a,5-tetramethyl-hexahydro-2h-naphthalen-1-yl]-3-methylpentanoic acid

C20H36O5 (356.2562606)


   

3-(hydroperoxymethyl)-6-[(2s)-2-hydroxydodecan-2-yl]-4-methoxypyran-2-one

3-(hydroperoxymethyl)-6-[(2s)-2-hydroxydodecan-2-yl]-4-methoxypyran-2-one

C19H32O6 (356.2198772)


   

(2s)-3-(acetyloxy)-2-{[(2z)-2-methylbut-2-enoyl]oxy}propyl nonanoate

(2s)-3-(acetyloxy)-2-{[(2z)-2-methylbut-2-enoyl]oxy}propyl nonanoate

C19H32O6 (356.2198772)


   

5-(5-chloro-3,4-dihydroxy-3-methylpentyl)-1,1,4a,6-tetramethyl-4,7,8,8a-tetrahydro-3h-naphthalen-2-one

5-(5-chloro-3,4-dihydroxy-3-methylpentyl)-1,1,4a,6-tetramethyl-4,7,8,8a-tetrahydro-3h-naphthalen-2-one

C20H33ClO3 (356.2118098000001)


   

6-[5-(but-2-en-2-yl)-4,11-dimethyl-3,10-dioxatetracyclo[5.5.0.0²,⁴.0⁹,¹¹]dodecan-6-yl]-3-methylhexa-3,5-dien-2-one

6-[5-(but-2-en-2-yl)-4,11-dimethyl-3,10-dioxatetracyclo[5.5.0.0²,⁴.0⁹,¹¹]dodecan-6-yl]-3-methylhexa-3,5-dien-2-one

C23H32O3 (356.23513219999995)


   

(1r,2s,5s,9r,12s,13r,16s)-16-(dimethylamino)-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-7,18-dien-8-ol

(1r,2s,5s,9r,12s,13r,16s)-16-(dimethylamino)-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-7,18-dien-8-ol

C23H36N2O (356.2827486)


   

1-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-3h,3bh,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}ethanone

1-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-3h,3bh,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}ethanone

C24H36O2 (356.2715156)


   

(1r,3r,4z,8e,11r)-4,7,7,11,17-pentamethyl-12-oxatricyclo[9.8.0.0¹³,¹⁸]nonadeca-4,8,13,15,17-pentaene-3,15-diol

(1r,3r,4z,8e,11r)-4,7,7,11,17-pentamethyl-12-oxatricyclo[9.8.0.0¹³,¹⁸]nonadeca-4,8,13,15,17-pentaene-3,15-diol

C23H32O3 (356.23513219999995)